| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Osteopenia | 2 | 2 | |
| Osteoporosis | 2 | 1 | |
| Bone pain | 1 | 0 | |
| Monoclonal gammopathy of undetermined significance | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 3 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Osteopenia | 2 | 2 | |
| Osteoporosis | 2 | 1 | |
| Bone pain | 1 | 0 | |
| Monoclonal gammopathy of undetermined significance | 1 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 3 |